Valuation: Mega Lifesciences

Market Cap 2.88TCr 86Cr 77Cr 71Cr 65Cr 121.79Cr 8.17TCr 123.75Cr 852.7Cr 334.32Cr 4.26TCr 323.14Cr 316.26Cr 14TCr P/E 2026 *
12.6x
P/E 2027 * 11.6x
Enterprise Value 2.42TCr 72Cr 64Cr 60Cr 54Cr 102.25Cr 6.86TCr 103.89Cr 715.87Cr 280.68Cr 3.58TCr 271.29Cr 265.51Cr 11TCr EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.55x
Free-Float
38.66%
Yield 2026 *
5.4%
Yield 2027 * 5.78%
1 day+0.76%
1 week-2.22%
Current month-2.22%
1 month-7.69%
3 months-12.58%
Current year-1.49%
1 week 32.5
Extreme 32.5
33.75
1 month 32.5
Extreme 32.5
36.75
Current year 31.5
Extreme 31.5
40
1 year 28.25
Extreme 28.25
40
3 years 24.3
Extreme 24.3
46
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap. Importance
29/04/25 Buy

Chief Executive Officer

1,00,000 0.0115%
28/04/25 Buy

Chief Executive Officer

50,000 0.0057%
28/04/25 Buy

Chief Executive Officer

1,50,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
+0.76%-2.22%+12.82%-26.26% 86Cr
+0.43%+6.59%+56.57%+106.64% 1,12000Cr
+0.90%-2.25%+32.26%+63.73% 62TCr
+0.71%+3.24%+24.33%+91.33% 50TCr
-0.13%+5.98%+33.66%+50.18% 37TCr
+0.52%+0.24%+72.13%+40.11% 36TCr
-0.95%+4.70%+19.65%+42.71% 29TCr
-1.98%+3.73%-0.89%+10.43% 26TCr
-0.35%+4.25%+44.74%+52.06% 23TCr
-0.75%+3.32%+27.18%+94.07% 19TCr
Average -0.08%+3.18%+32.25%+52.50% 39.42TCr
Weighted average by Cap. +0.13%+3.83%+39.33%+71.80%

Financials

2026 *2027 *
Net sales 1.43TCr 43Cr 38Cr 35Cr 32Cr 61Cr 4.07TCr 62Cr 424.7Cr 166.52Cr 2.12TCr 160.95Cr 157.52Cr 6.77TCr 1.55TCr 46Cr 41Cr 38Cr 35Cr 66Cr 4.4TCr 67Cr 459.34Cr 180.1Cr 2.3TCr 174.07Cr 170.37Cr 7.32TCr
Net income 224.3Cr 6.71Cr 5.97Cr 5.53Cr 5.03Cr 9.49Cr 637.06Cr 9.65Cr 66Cr 26Cr 332.44Cr 25Cr 25Cr 1.06TCr 248.59Cr 7.44Cr 6.61Cr 6.13Cr 5.58Cr 11Cr 706.04Cr 11Cr 74Cr 29Cr 368.44Cr 28Cr 27Cr 1.17TCr
Net Debt -461.67Cr -14Cr -12Cr -11Cr -10Cr -20Cr -1.31TCr -20Cr -136.82Cr -54Cr -684.25Cr -52Cr -51Cr -2.18TCr -471.98Cr -14Cr -13Cr -12Cr -11Cr -20Cr -1.34TCr -20Cr -139.88Cr -55Cr -699.52Cr -53Cr -52Cr -2.23TCr
Projected Income Statement - Annual - Mega Lifesciences
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
15/26/15 THB 33.00 +0.76% 8,93,356
14/26/14 THB 32.75 -0.76% 13,16,354
12/26/12 THB 33.00 -2.22% 21,83,479
09/26/09 THB 33.75 +1.50% 1,79,733
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Mega Lifesciences
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
33.00THB
Average target price
42.71THB
Spread / Average Target
+29.44%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Mega Lifesciences
  1. Stock Market
  2. Stocks
  3. MEGA Stock